Clinical trial
Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD): Randomized Controlled Trial
NCT05401019 is registered in ClinicalTrials.gov with Clinical Academic Center (2CA-Braga) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD): Randomized Controlled Trial
- Lead sponsor
- Clinical Academic Center (2CA-Braga)
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- June 30, 2022
- Completion date
- December 31, 2026
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.